Booster stocks

Booster stocks

Share this article


Amongst the overall declining stock market, you might guess that there were a few cheeky winners who rebelled and rose in prices this thanksgiving. Cue the booster stocks who secured a big win on Monday, with Covid vaccine companies announcing strain testing.

Moderna (MRNA) and FDA-approved Pfizer (PFE) announced that Omnicron might have the last laugh, as the teams are already geared up to test the effectiveness of current vaccines against the new strain.

And if worse comes to worst, we might even find new vaccine formulas specifically targeting the Omicron variant by early 2022.

This caused a bump in Moderna shares by 10% combined with a 1% rise in Pfizer prices, while the market made way to recovering its holiday panic spelldown.

Why it matters

When push comes to shove, you know that Moderna (MRNA) and Pfizer (PFE) have your back, immunity-wise and investment-wise. However, we’re curious to see the impact of this news on the global unvaxxed rates and on the newly-opened Expo 2020 gates this travel season.
akbaraka

Get Smarter
About Investing

Join 35,000+ subscribers and get our 5 min daily newsletter on daily local and international financial news.
akhbaraka
Get Smarter<br/> About Investing

Similar News